In vitro glucuronidation using human liver microsomes and the pore- forming peptide alamethicin

Drug Metabolism and Disposition

Volumn 28, Issue 5, 2000, Pages 560-566

  Fisher, Michael B ^a,b   Campanale, Kristina ^a   Ackermann, Bradley L ^a   Vandenbranden, Mark ^a   Wrighton, Steven A ^a  

^a ELI LILLY AND COMPANY   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 ETHOXYCOUMARIN; ALAMETHICIN; CYTOCHROME P450; ESTRADIOL; GLUCURONOSYLTRANSFERASE; MORPHINE; PARACETAMOL;

ARTICLE; CATALYSIS; CHANNEL GATING; CONJUGATION; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; GLUCURONIDATION; LIVER MICROSOME; PRIORITY JOURNAL; XENOBIOTIC METABOLISM;

ACETAMINOPHEN; ALAMETHICIN; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANTI-BACTERIAL AGENTS; COUMARINS; ESTRADIOL; GLUCURONIDES; GLUCURONOSYLTRANSFERASE; HUMANS; HYDROGEN-ION CONCENTRATION; KINETICS; MICROSOMES, LIVER; MORPHINE; OXIDATION-REDUCTION; TESTOSTERONE;

EID: 0034009448     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Banhegyi G, Bellomo G, Fulceri R, Mandl J and Benedetti A (1993) Intraluminal calcium of the liver endoplasmic reticulum stimulates the glucuronidation of p-nitrophenol. Biochem J 292:99-104.
2. Banhegyi G, Csala M, Mand J, Burchell A, Burchell B, Marcolongo P, Fulceri R and Benedetti A (1996) Fatty acyl-CoA esters and the permeability of rat liver microsomal vesicles. Biochem J 320:343-344.
3. Banhegyi G, Marcolongo P, Fulceri R, Hinds C, Burchell A and Benedetti A (1997) Demonstration of a metabolically active glucose-6-phosphate pool in the lumen of liver microsomal vesicles. J Biol Chem 272:13584-13590.
4. Berg CL, Radominska A, Lester R and Gollan JL (1995) Membrane translocation and regulation of uridine diphosphate-glucuronic acid uptake in rat liver microsomal vesicles. Gastroenterology 108:183-192.
5. Bock KW, Forster A, Gschaidmeier H, Bruck M, Munzel P, Schareck W, Fournel-Gigleux S and Burchell B (1993) Paracetamol glucuronidation by recombinant rat and human phenol UDP-glucuronosyltransferases. Biochem Pharmacol 45:1809-1814.
6. Bossuyt X and Blanckaert N (1996) Uridine diphosphoxylose enhances hepatic microsomal UDP-glucuronosyltransferase activity by stimulating transport of UDP-glucuronic acid across the endoplasmic reticulum membrane. Biochem J 315:189-193.
7. Bouska JJ, Bell RL, Goodfellow CL, Stewart AO, Brooks CDW and Carter GW (1997) Improving the in vivo duration of 5-lipoxygenase inhibitors. Drug Metab Dispos 25:1032-1038.
8. Bruni S and Chang TMS (1999) Kinetic studies of hepatocytes UDP-glucuronosyltransferase: Evidence of an allosteric enzyme. Art Cells Blood Subs and Immob Biotech 27:343-356.
9. Burchell B, Brierley CH and Rance D (1995) Specificity of human UDP-glucuronosyltransferases and xenobiotic glucuronidation. Life Sci 57:1819-1831.
10. Christrup LL (1997) Morphine metabolites. Acta Anaesthesiol Scand 41:116-122.
11. Coffman BL, Rios GR, King CD and Tephly TR (1997) Human UGT2B7 catalyzes morphine glucuronidation. Drug Metab Dispos 25:1-4.
12. Crespi CL, Miller VP and Penman BW (1998) High throughput screening for inhibition of cytochrome P450 metabolism. Med Chem Res 8:457-471.
13. Eddershaw PJ and Dickins M (1999) Advances in in vitro drug metabolism screening. Pharm Sci Technol Today 2:13-19.
14. Ekins S, Ring BJ, Binkley SN, Hall SD and Wrighton SA (1998) Autoactivation and activation of the cytochrome P450s. Intl J Clin Pharmacol Ther 36:642-651.
15. Ethell BT, Anderson GD, Beaumont K, Rance DJ and Burchell B (1998) A universal radiochemical high-performance liquid Chromatographic assay for the determination of UDP-glucuronosyltransferase activity. Anal Biochem 255:142-147.
16. Fulceri R, Banhegyi G, Gamberucci A, Giunti R, Mandl J and Benedetti A (1994) Evidence for the intraluminal positioning of p-nitrophenol UDP-glucuronosyltransferase activity in rat liver microsomes. Arch Biochem Biophvs 309:43-46.
17. Guengerich FP, Hosea NA, Parikh A, Bell-Parikh LC Johnson WW, Gillam EMJ and Shimada T (1998) Twenty years of biochemistry of human P450s: Purification, expression, mechanism, and relevance to drugs. Drug Metab Dispso 26:1175-1178.
18. Halvorson M, Greenway D, Eberhart D, Fitzgerald K and Parkinson A (1990) Reconstitution of testosterone oxidation by purified rat cytochrome P450p (IIIA1). Arch Biochem Biophys 277:166-180.
19. He K, Ludtke SJ, Heller WT and Huang HW (1996) Mechanism of alamethicin insertion into lipid bilayers. Biophys J 71:2669-2679.
20. Imaoka S, Imai Y, Shimada T and Funae Y (1992) Role of phospholipids in reconstituted cytochrome P450 3A form and mechanism of their activation of catalytic activity. Biochemistry 31:6063-6069.
21. Ito K, Iwatsubo T, Kanamitsu S, Ueda K, Suzuki H and Sugiyama Y (1998) Prediction of pharmacokinetic alterations caused by drug-drug interactions: Metabolic interaction in the liver. Pharmacol Rev 50:387-411.
22. Jedlitschky G, Cassidy AJ, Sales M, Pratt N and Burchell B (1999) Cloning and characterization of a novel human olfactory UDP-glucuronosyltransferase. Biochem J 340:837-843.
23. Kim JH, Johannes L, Goud B, Antony C, Lingwood CA, Daneman R and Grinstein S (1998) Noninvasive measurement of the pH of the endoplasmic reticulum at rest and during calcium release. Proc Natl Acad Sci (USA) 95:2997-3002.
24. Korzekwa KR, Krishnamachary N, Shou M, Ogai A, Parise RA, Rettie AE, Gonzalez FJ and Tracy TS (1998) Evaluation of atypical cytochrome P450 kinetics with two-substrate models: Evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites. Biochemistry 37:4137-4147.
25. Lett E, Kriszt W, de Sandro V, Ducrotoy G and Richert L (1992) Optimal detergent activation of rat liver microsomal UDP-glucuronosyltransferases toward morphine and 1-naphthol: Contribution to induction and latency studies. Biochem Pharmacol 43:1649-1653.
26. Little JM, Lehman PA, Nowell S, Samokyszyn V and Radominska A (1997) Glucuronidation of all-trans-retinoic acid and 5,6-epoxy-all-trans-retinoic acid. Drug Metab Dispos 25:5-11.
27. Mackenzie PI (1995) The UDP-glucuronosyltransferase multigene family, in Rev Biochem Toxicol (Hodgson E, Bend JR and Philpot RM eds) 11: 29-72. Toxicology Communications Inc., Raleigh, NC.
28. Mackenzie PI, Owens IS, Burchell B, Bock KW, Bairoch A, Belanger A, Fournel-Gigleux S, Green M, Hum DW, Iyanagi T, Lancet D, Louisot P, Magdalou J, Chowdhury JR, Ritter JK, Schachter H, Tephly TR, Tipton KF and Nebert DW (1997) The UDP-glycosyltransferase gene superfamily: Recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7:255-269.
29. Meech R and Mackenzie PI (1997) Structure and function of uridine diphosphate glucuronosyltransferases. Clin Exp Pharmacol Physiol 24:907-915.
30. Miners JO and Mackenzie PI (1991) Drug glucuronidation in humans. Pharmacol Ther 51:347-369.
31. Patten CJ, Leakey JAE, Frame LT and Crespi CL (1998) Heterologous expression of human UDP-glucuronosyl transferases. ISSX Proc 13:197.
32. Puskas F, Braun L, Csala M, Kardon T, Marcolongo P, Benedetti A, Mandl J and Banhegyi G (1998) Gulonolactone oxidase activity-dependent intravesicular glutathione oxidation in rat liver microsomes. FEBS Lett 430:293-296.
33. Rodrigues AD (1994) Use of in vitro human metabolism studies in drug development. Biochem Pharmacol 48:2147-2156.
34. Rowland M and Tozer TN (1995) Clinical Pharmacokinetics: Concepts and Applications. 3rd ed., Williams and Wilkins, Media, PA.
35. Senafi SB, Clarke DJ and Burchell B (1994) Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation. Biochem J 303:233-240.
36. 2+ in permeabilized smooth muscle cells with use of furaptra. Am J Physiol 269 (Cell Physiol 38): C698-C705.
37. Trapnell CB, Klecker RW, Jamis-Dow C and Collins JM (1998) Glucuronidation of 3′-azido-3′-deoxythymidine (zidovudine) by human liver microsomes-relevance to clinical pharmacokinetic interactions with atovaquone, fluconazole, methadone, and valproic acid. Antimicrob Agents Chemother 42:1592-1596.
38. van der Hoeven TA and Coon MJ (1974) Preparation and properties of partially purified cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase from rabbit liver microsomes. J Biol them 249:6302-6310.
39. Vanstapel F and Blanckaert N (1988) Topology and regulation of bilirubin UDP-glucuronyltransferase in sealed native microsomes from rat liver. Arch Biochem Biophys 263:216-225.
40. Wang T-F and Guidotti G (1998) Golgi localization and functional expression of human uridine diphosphatase. J Biol Chem 273:11392-11399.
41. Zakim D, Goldenberg J and Vessey DA (1973) Effects of metals on the properties of hepatic microsomal uridine diphosphate glucuronyltransferase. Biochemistry 12:4068-4074.